Once the patent of a biopharmaceutical expires, often several biosimilars enter the market. While comparable in the effect, their costs are much lower.
Find our what distinguishes biosimilars is the contribution they provide for the supply with biopharmaceuticals and which actors of the health care system benefit from them here.
How are biosimilars manufactured, what distinguishes them from the original biopharmaceutical, and who decides whether patients receive a biosimilar or the original? We have answered questions like these for you here.
The functioning competition in the German biosimilar market results in massive savings and improve the supply of biopharmaceuticals. Here we introduce the positive effects of biosimilars.
